U.S. FDA Licenses Certara’s Immunogenicity Simulator
February 23, 2022 16:30 ET
|
Certara
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has licensed...
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
February 15, 2022 16:30 ET
|
Certara
PRINCETON, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that 90 percent of new drug approvals by the U.S. Food and Drug...
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
February 08, 2022 16:30 ET
|
Certara
PRINCETON, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and...
Insights on the Biosimulation Global Market to 2026 - Featuring Certara, Evidera and Gendata Among Others
January 06, 2022 03:58 ET
|
Research and Markets
Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "Biosimulation Market Research Report by Product & Service, Delivery Model, End-user, Application, and Region - Global Forecast to 2026 - Cumulative...
Global Biosimulation Market Research Report 2021-2028 - Surging Demand for Biosimulation Software & Services due to their Higher Cost-Efficiency
December 30, 2021 07:48 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market Size, Share & Trends Analysis Report by Product (Software, Services), by Application (Drug Development, Drug...
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
December 21, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has renewed and...
Certara Announces Release of Pinnacle 21 Enterprise Software
December 13, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates...
Certara to Host Investor Day on December 15, 2021
December 08, 2021 17:00 ET
|
Certara
PRINCETON, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, will host an Investor Day on Wednesday, December 15, 2021 from 3:00 PM to 6:00 PM...
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
December 02, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 21, which updates the...
Certara Announces Closing of Public Offering of Common Stock
November 22, 2021 17:45 ET
|
Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...